Create a narrative

Geron Community

NasdaqGS:GERN Community

2 Narratives written by author
1 Comments on narratives written by author
30 Fair Values set on narratives written by author

Create a narrative

WA

WaneInvestmentHouse

WaneInvestmentHouse

Community Contributor

Q1 2025 Earnings Call Highlights: Navigating Revenue Challenges and Strategic amid investor court case

Release Date: May 07, 2025 Q1 RYTELO Net Revenues: $39.4 million, down $8 million from Q4. Cash and Marketable Securities: Approximately $457.5 million as of March 31, 2025.

US$2.42

FV

46.7% undervalued

98.00%

Revenue growth p.a.

0

1

4

2 months ago

AN

AnalystConsensusTarget

AnalystConsensusTarget

Consensus Narrative from 9 Analysts

EU Approval And US Initiatives Will Expand Future Markets

Key Takeaways European expansion with RYTELO's approval and launch could significantly boost revenue through international growth and increased market reach. Strategic improvements in operations, leadership, and medical engagement aim to capture U.S. market opportunities and increase RYTELO adoption, enhancing revenue growth.

US$6.16

FV

79.1% undervalued

86.49%

Revenue growth p.a.

0

0

17

1 day ago